|Prof. Lebin Wu||Chairman, Compliance Officer and Director of Baiao Pharmaceuticals||156.25k||N/A||55|
|Mr. Chen Jintian||Vice-Chairman, Chief Exec. Officer and Pres||93k||N/A||39|
|Dr. Cunmao Xu||VP, Sec. and Exec. Director||95.9k||N/A||54|
|Mr. Haitao Zhang||VP and Exec. Director||106.63k||N/A||44|
|Mr. Woon Cheung Tung CPA, CPA, (U.S)||Company Sec.||N/A||N/A||46|
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products primarily in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; analyzers, such as flow cytometers and clinical chemistry analyzers; Elisa kits; and rapid tests. It also provides medical and medical inspection services; produces medical instruments; distributes immunodiagnostic products; and offers investment management services, as well as consulting services related to non-securities business and equity investment management. The company also exports its products to approximately 40 countries in Asia, Africa, and East Europe. Biosino Bio-Technology and Science Incorporation was founded in 1988 and is based in Beijing, the Peoples Republic of China.
Biosino Bio-Technology and Science Incorporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.